Cancer Cell Manufacturers, Suppliers & Companies
-
Samyang succeeded in localizing fine materials by producing ion exchange resins in Korea for the first time through a technical partnership with Japan's Mitsubishi Chemical in 1976. Samyang Fine Technology is a joint venture established and invested ...
Nanoxel - Model M - Injection
Used to treat breast cancer, non-small-cell lung cancer, prostate cancer, ovarian cancer, head and neck cancer, and esophageal ...
CONTACT SUPPLIER -
Environics Inc. is a world leader in computerized gas flow instrumentation for gas mixers, gas dilution and calibration systems. Our headquarters for design, manufacturing, sales and service is located in a modern 11,000 square foot facility in ...
-
Created in 2006, it4ip S.A. is a private company based on technologies developed at the UCLouvain (Belgium) in the 80’s. it4ip is also the acronym of “Ion track Technology 4 Innovative Products“, reflecting the group of 4 people being at the origin ...
-
Manufacturerbased in Santa Clara, CALIFORNIA (USA)
Filtricine, Inc. is a clinical stage biotechnology company focused on developing novel products for cancer management. We are backed by venture capital and located in the San Francisco Bay Area of California. We are developing an innovative way to ...
Engineering the Death of Cancer Cells
The hyperactive metabolism of cancer cells is extensively modified to support their unsustainable consumption of nutrients, which is what allows cancer cells to reproduce rapidly. ...
CONTACT SUPPLIER -
Manufacturerbased in Didcot, UNITED KINGDOM
We design, develop and manufacture nanofibrous biomaterials for medical devices and regenerative medicine. Our technology platform is built on electrospinning and associated processing technologies. We are supporting clients with material ...
Electrospinning - Model MCF7 - Breast Cancer Cells
The Mimetix fibres are labelled with Rhodamine 6G. The thickness of Mimetix scaffold allows for having a 3D environment while maintaining a certain translucence, thus allowing for easy and robust imaging. This study has investigated the localisation ...
CONTACT SUPPLIER -
Manufacturerbased in West Vancouver, BRITISH COLUMBIA (CANADA)
Focusing initially on breast cancer, BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX:BCT) is dedicated to enhancing the lives of people with cancer with limited therapy options by developing novel immunotherapies to fight cancer. ...
BriaCell - Model Bria-IMT and Bria-OTS - Destroy Cancer Cells
The mechanism of action of Bria-IMT™/Bria-OTS™ is currently under investigation. We believe that Bria-IMT™/Bria-OTS™, activates the patient’s immune system to recognize tumor cells and destroy them. We ...
CONTACT SUPPLIER -
Manufacturerbased in Amsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
Model K-NK003 - NK Cells for Cancer Immunotherapeutics
K-NK003: A phase 1 study evaluating NK cells as a treatment for patients with relapse and refractory acute myeloid leukemia (AML). This study was designed based on promising clinical proof-of-concept data from two studies, one at MD ...
CONTACT SUPPLIER -
Manufacturerbased in Paris, FRANCE
Oncovita is a biotech company developing a disruptive virus-derived vaccine technology to treat multiple types of cancers. Our MeasovirTM platform was developed based on the safe and highly immunogenic measles virus vaccine, a vaccine with ...
Measovir - Platform to Kill Cancer Cells and Activate Immune System
Oncovita’s MeasovirTM proprietary platform relies on a DNA plasmid vector that expresses a modified measles Schwarz virus antigenome able to generate recombinant viruses by using a clonal reverse genetics system. This versatile plug-and-play ...
CONTACT SUPPLIER -
Manufacturerbased in Emeryville, CALIFORNIA (USA)
Gritstone is developing targeted immunotherapies for cancer and infectious disease. Gritstone’s approach seeks to generate a therapeutic immune response by leveraging insights into the immune system’s ability to recognize and destroy diseased cells ...
Gritstone - Model EDGE - Cancer Cell Therapies
We are leveraging EDGE to define targets for T-cell receptor (TCR) directed cell therapies. These additional targets that were identified and validated by Gritstone EDGE™ enable us to partner with others or ...
CONTACT SUPPLIER -
Manufacturerbased in Bedminster, NEW JERSEY (USA)
Jubilant Therapeutics Inc. is a clinical stage precision therapeutics company advancing potent and selective small molecule modulators to address unmet medical needs in oncology and autoimmune diseases. With an advanced discovery engine which ...
Model LSD1/HDAC6 - Cancer Stem Cell
Strong scientific and clinical rationale for LSD1/HDAC6 inhibition in haematological and solid ...
CONTACT SUPPLIER -
Manufacturerbased in Golden, COLORADO (USA)
At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar ...
Vitro - Human Prostate Cancer Associated Fibroblasts: 1,000,000 Cells Per Vial
High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for high growth rates, reduced doubling times, healthy cells, and stability). Able to grow in low oxygen ...
CONTACT SUPPLIER -
Technologybased in Paris, FRANCE
The mission of Alderaan Biotechnology is to develop novel therapies to treat cancer by targeting cells from the immune system. Alderaan Biotechnology programs are related to the elimination of Regulatory T cells and to the hyper activation of ...
Model CD160TM - Natural Killer Cells
CD160TM NK cell boost using CD160-TM specific monoclonal antibodies. Natural Killer cells (NK) represents a cell population involved in the cancer cell destruction ...
CONTACT SUPPLIER -
Manufacturerbased in CHINA
Mol Scientific provides customized peptide synthesis services including linear peptides, modified peptides, protein cross-linked peptides and more. Mol Scientific is a national high-tech enterprise, committed to providing high quality products and ...
Mol Scientific - Model MPE0003430 - Cancer cell proliferation inhibitor peptide
Mol Scientific offer high-quality Cancer cell proliferation inhibitor peptide product(MPE0003430). Mol Scientific committed to bring our esteemed customers high quality products and the finest services at highly ...
CONTACT SUPPLIER -
Technologybased in Auburndale, MASSACHUSETTS (USA)
Imagin Medical, a surgical imaging company, is focusing on bladder cancer, the sixth most prevalent cancer in the U.S. and the third most common cancer in men. It is the most expensive form of cancer to treat over the lifetime of a patient because ...
Cystoscopy with Blue Light
Introduced in 2010, blue light cystoscopy, uses blue-filtered white light to address the limitations of white light cystoscopy. This method involves administering a contrast agent into the bladder which is absorbed by the cancerous ...
CONTACT SUPPLIER -
Manufacturerbased in Cambridge, MASSACHUSETTS (USA)
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer. Leveraging decades of industry learnings, we have developed proprietary and highly ...
Dolasynthen
generate ADCs with precisely defined DARs for consistent drug delivery to cancer cells. The Dolasynthen scaffold has been precisely balanced to provide optimal water solubility, charge balance, linker stability and ...
CONTACT SUPPLIER -
Manufacturerbased in Guildford, UNITED KINGDOM
Datar Cancer Genetics is a leader in developing blood-based diagnostics that can detect cancer early, offer non-invasive investigations for better treatment options, and track the progression of the disease or its recurrence. We believe that ...
Trucheck - Screening Technology
Trucheck is an advanced non-invasive blood test which provides evidence of an underlying malignancy via a safe, simple and quick blood draw. Trucheck™ evaluates blood sample to detect ‘Circulating Tumor Cells’ ...
CONTACT SUPPLIER -
Manufacturerbased in Haifa, ISRAEL
Pluristem Therapeutics Inc. is a clinical-stage regenerative medicine company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for conditions such as inflammation, muscle injuries, ...
Pluristem - Model PLX-Immune - Cells for Tumor Necrosis Factor Alpha (TNF-a) and Interferon-Gamma (IFN-g)
in over 50 lines of human cancerous cells. The results showed that PLX-Immune cells exhibited an anti-proliferative effect on 45 percent of the tested cancer cell ...
CONTACT SUPPLIER -
Technologybased in Newtown, PENNSYLVANIA (USA)
Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing products for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways ...
Onconova - Rigosertib - Small Molecule
Rigosertib is a small molecule that inhibits multiple cellular signaling pathways driving cancer cell growth while having little effect on normal cells. In contrast to many kinase inhibitors, ...
CONTACT SUPPLIER -
Manufacturerbased in Cambridge, UNITED KINGDOM
Biosceptre is a biopharmaceutical company focused on chimeric antigen receptor (CAR) T-cell therapy and immune-oncology treatment, that’s committed to bringing a new range of targeted therapies to a wide range of cancer patients. With Nobel ...
CAR T-Cell Therapy
CAR T-cell therapy is the engineering of a patient’s T cells, a type of white blood cell. A small portion of these cells are collected, from a patient’s blood sample, ...
CONTACT SUPPLIER -
Manufacturerbased in Tuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Immatics TCER - Bispecific T cell Engaging Receptors
Bispecific T cell engaging receptors (TCER®) are off-the-shelf biologics that leverage the body’s immune system by redirecting and activating T cells towards cancer cells ...
CONTACT SUPPLIER
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you